These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26101712)

  • 41. ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14.
    Zhang Y; Sun M; Gao L; Liang X; Ma C; Lu J; Yue X
    Cancer Cell Int; 2022 Feb; 22(1):76. PubMed ID: 35151335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR-132 suppresses the migration and invasion of lung cancer cells by blocking USP9X-induced epithelial-mesenchymal transition.
    Guo H; Zhang X; Chen Q; Bao Y; Dong C; Wang X
    Am J Transl Res; 2018; 10(1):224-234. PubMed ID: 29423007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
    Wei L; Qin XP; Zhao XX; Wang W
    Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
    [No Abstract]   [Full Text] [Related]  

  • 44. Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial-mesenchymal transition.
    Chen X; Lan K; Liu Q; Yang X; Wang H
    Tumour Biol; 2017 Mar; 39(3):1010428317695942. PubMed ID: 28351308
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.
    Zhang X; Zhao X; Li Y; Zhou Y; Zhang Z
    J Cell Physiol; 2019 Aug; 234(10):17494-17504. PubMed ID: 30912129
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
    Yu J; Han Q; Cui Y
    Tumour Biol; 2017 Jul; 39(7):1010428317709129. PubMed ID: 28691641
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Upregulation of
    Wu L; Ling ZH; Wang H; Wang XY; Gui J
    Cancer Biother Radiopharm; 2019 Dec; 34(10):642-649. PubMed ID: 31549859
    [No Abstract]   [Full Text] [Related]  

  • 48. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SATB1 promotes epithelial-mesenchymal transition and metastasis in prostate cancer.
    Qi H; Fu X; Li Y; Pang X; Chen S; Zhu X; Li F; Tan W
    Oncol Lett; 2017 Apr; 13(4):2577-2582. PubMed ID: 28454436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidermal growth factor receptor kinase substrate 8 promotes the metastasis of cervical cancer via the epithelial-mesenchymal transition.
    Li Q; Bao W; Fan Q; Shi WJ; Li ZN; Xu Y; Wu D
    Mol Med Rep; 2016 Oct; 14(4):3220-8. PubMed ID: 27573546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
    Cheng KY; Hao M
    Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Twist2, the key Twist isoform related to prognosis, promotes invasion of cervical cancer by inducing epithelial-mesenchymal transition and blocking senescence.
    Wang T; Li Y; Wang W; Tuerhanjiang A; Wu Z; Yang R; Yuan M; Ma D; Wang W; Wang S
    Hum Pathol; 2014 Sep; 45(9):1839-46. PubMed ID: 24974259
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
    Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH
    Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Expression of LIM and SH3 protein 1 in renal clear cell carcinoma and its effects on invasion and migration of renal clear cell carcinoma 786-O cells].
    Jin B; Gao L; Li W; Chen JC; Wen RM; Wang JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):166-171. PubMed ID: 28316213
    [No Abstract]   [Full Text] [Related]  

  • 56. Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation.
    Lee MY; Chou CY; Tang MJ; Shen MR
    Clin Cancer Res; 2008 Aug; 14(15):4743-50. PubMed ID: 18676743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TBX2 overexpression promotes proliferation and invasion through epithelial-mesenchymal transition and ERK signaling pathway.
    Liu X; Miao Z; Wang Z; Zhao T; Xu Y; Song Y; Huang J; Zhang J; Xu H; Wu J; Xu H
    Exp Ther Med; 2019 Jan; 17(1):723-729. PubMed ID: 30651856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
    Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
    J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
    Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
    Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression profile and functional role of S100A14 in human cancer.
    Basnet S; Sharma S; Costea DE; Sapkota D
    Oncotarget; 2019 Apr; 10(31):2996-3012. PubMed ID: 31105881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.